JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 16, 2008, 10.2967/jnumed.107.048603
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, M.
Right arrow Articles by Bugenhagen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, M.
Right arrow Articles by Bugenhagen, S.

99mTc-Labeled Duramycin as a Novel Phosphatidylethanolamine-Binding Molecular Probe

Ming Zhao, Zhixin Li and Scott Bugenhagen

Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin


Figure 1
View larger version (18K):
[in this window]
[in a new window]

 
FIGURE 1.  (A) Diagram illustrating primary structure of duramycin with cross-linking bridges. (B and C) Radio-HPLC chromatograms of 99mTc-duramycin before and after purification are shown in B and C, respectively. Low, but significant, level of 99mTc-pertechnetate is present before purification with retention time of 2 min. (D) Representative competition curve of 3 independent experiments. 99mTc-duramycin binding of apoptotic cells is competitively diminished by presence of PtdE-containing liposomes (•) but not other phospholipid species, including PtdC ({blacksquare}), PtdG ({square}), or PtdS ({circ}). cpm = counts per minute.

 

Figure 2
View larger version (13K):
[in this window]
[in a new window]

 
FIGURE 2.  (A) Blood clearance of 99mTc-duramycin in healthy rats (n = 3). (B–E) Radio-HPLC chromatograms of 99mTc-duramycin standard (B), serum at 1 min after injection (C), serum at 5 min after injection (D), and urine at 60 min after injection (E).

 

Figure 3
View larger version (68K):
[in this window]
[in a new window]

 
FIGURE 3.  (A) Dynamic planar imaging of 99mTc-duramycin distribution in healthy rat. Note rapid renal clearance of radiotracer and low hepatic uptake. (B) Whole-body dynamic planar imaging of 99mTc-duramycin uptake in rat with acute myocardial infarction. (C) Non–color-enhanced, raw counts of static planar images of sham-operated rat (left) and infarcted rat (right) acquired at 120 min after intravenous injection of 99mTc-duramycin. Infarct site is marked by arrows. In autoradiography, radioactivity uptake in myocardium colocalizes with infarct with excellent infarct-to-noninfarct ratio (inset). B = bladder; K = kidney.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.